JUNIPER PHARMACEUTICALS INC Deferred Tax Assets, in Process Research and Development
JUNIPER PHARMACEUTICALS INC had Deferred Tax Assets, in Process Research and Development of $1.72 million as of 2014-12-31, per its 10-K filed 2015-03-18.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2015-03-18
- 2014-12-31: Deferred Tax Assets, in Process Research and Development $1.72M.
- 2013-12-31: Deferred Tax Assets, in Process Research and Development $1.74M; Deferred Tax Assets, in Process Research and Development as first filed $1.74M.
- 2012-12-31: Deferred Tax Assets, in Process Research and Development $1.96M.
- 2011-12-31: Deferred Tax Assets, in Process Research and Development $1.87M.
| Period end | Deferred Tax Assets, in Process Research and Development | Deferred Tax Assets, in Process Research and Development as first filed |
|---|---|---|
| 2014-12-31 | $1.72M 10-K · filed 2015-03-18 | |
| 2013-12-31 | $1.74M 10-K · filed 2015-03-18 | $1.74M 10-K · filed 2014-03-05 |
| 2012-12-31 | $1.96M 10-K · filed 2014-03-05 | |
| 2011-12-31 | $1.87M 10-K · filed 2013-03-14 |